Home Bracco-Eisai

Statement of Bracco Imaging CEO Fulvio Renoldi Bracco on the COVID-19 outbreak
BRACCO CARES
is responding to the
COVID-19 outbreak.

Click here to learn more.
Engaged in the providing products and solutions useful for diagnosis and treatment in the diagnostic imaging area that address the evolving needs of patients
Bracco-Eisai
founded in 1990
is specialized in the
diagnostic imaging area.
Imaging products with various formulations that meet diverse medical challenges.

Statement of Bracco Imaging CEO Fulvio Renoldi Bracco on the COVID-19 outbreak
BRACCO CARES is responding to the COVID-19 outbreak.
Click here to learn more.
Engaged in the providing products and solutions useful for diagnosis and treatment in the diagnostic imaging area that address the evolving needs of patients
Bracco-Eisai founded in 1990, is specialized in the diagnostic imaging area.
Imaging products with various formulations that meet diverse medical challenges.

Highlights

1990

Founded Bracco-Eisai Joint Venture in Japan

1994

Launched the non-ionic iodinated contrast agent in the X-Ray/CT market

1996

Established Saitama plant at Honjo City, Saitama Prefecture

1999

Succeeded the import approval of macrocylcic non-ionic contrast agent for MRI

2015

The 25th Anniversary of the foundation

Highlights

Copyright © 2020 Bracco - Bracco-Eisai Co.,Ltd.

BRACCO-EISAI CO.,LTD.
3-11-6, Otsuka, Bunkyo-ku,
Tokyo 112-0012, Japan
Tel +81 3-5319-3381

SAITAMA PLANT
262-3, Nishi-Tomita, Honjo-shi,
Saitama-ken 367-0035, Japan
Tel +81 495-21-8588